Udder Health Market worth $1.6 billion by 2029

(EMAILWIRE.COM, October 15, 2024 ) The global udder health market is expected to grow from USD 1.2 billion in 2024 to USD 1.6 billion by 2029, at a CAGR of 5.9%. The udder health market is experiencing growth driven by increasing investments and government funding, alongside a rising number of veterinarians in developing countries. However, the market faces challenges due to lack of awareness among small-scale dairy farmers. Key drivers include the prevalence of bovine mastitis and other udder health disorders, necessitating advanced diagnostics and treatments. Opportunities arise from increasing per capita income among farmers in developing nations, while regulatory controls pose challenges for market players. Major companies in the market include Vetoquinol S.A., Zoetis Inc., Merck & Co., Inc., Virbac, Ecolab, and Boehringer Ingelheim GmbH.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76741813&utm_source=emailwire.com&utm_medium=referral&utm_campaign=udderhealthmarket

Browse in-depth TOC on “Udder Health Market”

250 – Tables
200 – Figures
300 – Pages

DeLaval (Sweden): Leader in Dairy Farming Solutions

DeLaval, headquartered in Tumba, Sweden, specializes in dairy farming solutions globally. The company focuses on milking equipment, hygiene products, and farm supplies across over 100 markets, with notable operations in dairy-rich regions like the USA, Canada, and China. Acquiring Milkrite | InterPlus in 2020 expanded DeLaval’s portfolio in milking point solutions, solidifying its position as a global leader in the dairy industry.

Zoetis Inc. (US): Global Leader in Animal Health

Zoetis, a leading global entity in animal health based in the US, develops, manufactures, and markets vaccines and medicines for livestock and companion animals. With operations spanning 70 countries and products available in over 120 countries, Zoetis is known for its comprehensive portfolio in intramammary antibiotic therapies critical for treating mastitis in dairy cows. Recent expansions, such as acquiring a manufacturing site in Melbourne, Australia, underscore Zoetis’ commitment to enhancing global operations and product offerings.

Boehringer Ingelheim GmbH (Germany): Prominent in Animal Health

Boehringer Ingelheim, a renowned pharmaceutical company based in Germany, focuses on human and animal health. Within its Animal Health segment, the company offers a wide range of pharmaceutical care products, including parasiticides for food-producing and companion animals. With a presence in 146 subsidiaries worldwide, Boehringer Ingelheim maintains a strong global footprint and emphasizes innovation in biological and pharmaceutical solutions for animal health.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76741813&utm_source=emailwire.com&utm_medium=referral&utm_campaign=udderhealthmarket

Product Segmentation: Supplements Gain Traction

The udder health market is segmented by product type into devices, pharmaceuticals, and supplements. As of 2023, the supplements segment held the third largest market share. This growth is driven by increased adoption among dairy farmers seeking comprehensive udder health support.

Type Segmentation: Dairy Farms Dominate

In terms of veterinary care setting, the market includes dairy farms and veterinary hospitals and clinics. In 2023, dairy farms accounted for the largest share due to rising mastitis cases among dairy cattle. To combat this, dairy farms are investing in advanced technologies for early detection and efficient treatment of mastitis.

Animal Type Segmentation: Dairy Cattle Lead

The udder health market is divided by animal type into dairy cattle and other animals. Dairy cattle held the largest market share in 2023. This dominance is attributed to intensive management practices for milk production, heightened susceptibility to udder infections, and increased adoption of advanced health management practices among dairy farmers.

Disease Type Segmentation: Clinical Mastitis Shows Rapid Growth

Among disease types, the clinical mastitis segment demonstrated the fastest CAGR in 2023. This growth is fueled by its significant impact on dairy production, including reduced milk yield and higher treatment costs. Increased awareness and technological advancements contribute to the prominence of clinical mastitis management in the market.

Regional Insights: APAC Emerges as a Key Market

Geographically, APAC held the third largest market share in 2023. This leadership is bolstered by government support for dairy farming, advancements in veterinary healthcare infrastructure, and technological innovations. These factors collectively foster a conducive environment for the adoption of udder health solutions, driving market growth in the region.